- Home
- WK vs LNTH Comparison
WK vs LNTH Comparison
Compare WK & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WK
- LNTH
- Stock Information
- Founded
- WK 2008
- LNTH 1956
- Country
- WK United States
- LNTH United States
- Employees
- WK N/A
- LNTH N/A
- Industry
- WK Computer Software: Prepackaged Software
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- WK Technology
- LNTH Health Care
- Exchange
- WK Nasdaq
- LNTH Nasdaq
- Market Cap
- WK 5.0B
- LNTH 3.8B
- IPO Year
- WK 2014
- LNTH 2015
- Fundamental
- Price
- WK $91.22
- LNTH $52.26
- Analyst Decision
- WK Strong Buy
- LNTH Buy
- Analyst Count
- WK 10
- LNTH 6
- Target Price
- WK $104.50
- LNTH $74.17
- AVG Volume (30 Days)
- WK 722.0K
- LNTH 1.4M
- Earning Date
- WK 11-05-2025
- LNTH 11-06-2025
- Dividend Yield
- WK N/A
- LNTH N/A
- EPS Growth
- WK N/A
- LNTH N/A
- EPS
- WK N/A
- LNTH 2.39
- Revenue
- WK $845,522,000.00
- LNTH $1,525,933,000.00
- Revenue This Year
- WK $21.54
- LNTH N/A
- Revenue Next Year
- WK $15.73
- LNTH $1.98
- P/E Ratio
- WK N/A
- LNTH $21.18
- Revenue Growth
- WK 19.86
- LNTH 1.95
- 52 Week Low
- WK $60.50
- LNTH $47.25
- 52 Week High
- WK $116.83
- LNTH $111.29
- Technical
- Relative Strength Index (RSI)
- WK 62.41
- LNTH 41.10
- Support Level
- WK $84.48
- LNTH $50.16
- Resistance Level
- WK $97.10
- LNTH $61.92
- Average True Range (ATR)
- WK 3.25
- LNTH 2.45
- MACD
- WK 0.14
- LNTH -0.68
- Stochastic Oscillator
- WK 64.60
- LNTH 17.38
About WK Workiva Inc.
Workiva Inc is a cloud-native platform that simplifies the complexities of reporting and compliance. Workiva platform empowers customers by connecting and transforming data from hundreds of enterprise resource planning (ERP), human capital management (HCM), and customer relationship management (CRM) systems, as well as other third-party cloud and on-premise applications. Customers use the platform to create, review and publish data-linked documents and reports with greater control, consistency, accuracy, and productivity and it is also used for SEC Filings. Company's Geographical region consist of USA, Netherland, UK, and Others. Majority of revenue is from USA.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.